secwatch.observer — SEC 8-K summary
======================================

Issuer:     CITIUS ONCOLOGY, INC. (CTOR)
CIK:        0001851484
Form:       8-K
Filed at:   2023-10-18T23:59:59+00:00
Accession:  0001493152-23-037635
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TenX Keane Acquisition extends deadline to Jan 18, 2024; deposits $660K
-----------------------------------------------------------------------

- Deposited $660,000 ($0.10 per public share) into trust to extend combination deadline to January 18, 2024.
- Sponsor 10XYZ Holdings LP provided the extension fee via an unsecured promissory note.
- Sponsor may convert up to $1.5M of the note into private units at $10.00 per unit (one share + 2/10 right per unit).
- Company had until October 18, 2023 to complete initial business combination prior to extension.
- Extension is the first of two possible three-month extensions permitted under the charter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1851484/000149315223037635/0001493152-23-037635-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1851484/000149315223037635/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-037635

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer